Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biol Trace Elem Res ; 152(2): 292-6, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23334864

RESUMEN

Iron overload has recently been connected with bone mineral density in osteoporosis. However, to date, the effect of iron overload on osteoblasts remains poorly understood. The purpose of this study is to examine osteoblast biological activity under iron overload. The osteoblast cells (hFOB1.19) were cultured in a medium supplemented with different concentrations (50, 100, and 200 µM) of ferric ammonium citrate as a donor of ferric ion. Intracellular iron was measured with a confocal laser scanning microscope. Reactive oxygen species (ROS) were detected by 2,7-dichlorofluorescin diacetate fluorophotometry. Osteoblast biological activities were evaluated by measuring the activity of alkaline phosphatase (ALP) and mineralization function. Results indicated that iron overload could consequently increase intracellular iron concentration and intracellular ROS levels in a concentration-dependent manner. Additionally, ALP activity was suppressed, and a decline in the number of mineralized nodules was observed in in vitro cultured osteoblast cells. According to these results, it seems that iron overload probably inhibits osteoblast function through higher oxidative stress following increased intracellular iron concentrations.


Asunto(s)
Sobrecarga de Hierro/metabolismo , Hierro/toxicidad , Osteoblastos/metabolismo , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Línea Celular , Humanos , Sobrecarga de Hierro/fisiopatología , Osteoblastos/efectos de los fármacos
2.
Biol Trace Elem Res ; 150(1-3): 487-95, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23054865

RESUMEN

Bone metabolism has a close relationship with iron homeostasis. To examine the effects of iron excess and iron deficiency on the biological activities of osteoblast in vitro, human osteoblast cells (hFOB1.19) were incubated in a medium supplemented with 0-200 µmol/L ferric ammonium citrate and 0-20 µmol/L deferoxamine. The intracellular iron was measured by a confocal laser scanning microscope. Proliferation of osteoblasts was evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. Apoptotic cells were detected using annexin intervention V/PI staining with a flow cytometry. Alkaline phosphatase (ALP) activity was measured using an ALP assay kit. The number of calcified nodules and mineral area was evaluated by von Kossa staining assay. The expressions of type I collagen and osteocalcin of cultured osteoblasts were detected by reverse transcriptase polymerase chain reaction and Western blot. Intracellular reactive oxygen species (ROS) was measured using the oxidation-sensitive dye 2,7-dichlorofluorescin diacetate by flow cytometry. The results indicated that excessive iron inhibited osteoblast activity in a concentration-dependent manner. Low iron concentrations, in contrast, produced a biphasic manner on osteoblasts: mild low iron promoted osteoblast activity, but serious low iron inhibited osteoblast activity. Osteogenesis was optimal in certain iron concentrations. The mechanism underlying biological activity invoked by excessive iron may be attributed to increased intracellular ROS levels.


Asunto(s)
Anemia Ferropénica/metabolismo , Sobrecarga de Hierro/metabolismo , Hierro/metabolismo , Osteoblastos/metabolismo , Fosfatasa Alcalina/metabolismo , Anemia Ferropénica/patología , Apoptosis/efectos de los fármacos , Calcificación Fisiológica/efectos de los fármacos , Línea Celular , Proliferación Celular/efectos de los fármacos , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Deferoxamina/farmacología , Suplementos Dietéticos/efectos adversos , Compuestos Férricos/efectos adversos , Compuestos Férricos/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Hormesis , Humanos , Hierro/envenenamiento , Deficiencias de Hierro , Sobrecarga de Hierro/patología , Osteoblastos/citología , Osteoblastos/efectos de los fármacos , Osteoblastos/patología , Osteocalcina/genética , Osteocalcina/metabolismo , Osteogénesis/efectos de los fármacos , Compuestos de Amonio Cuaternario/efectos adversos , Compuestos de Amonio Cuaternario/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Sideróforos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA